Role of Anifrolumab in Refractory Cutaneous Manifestations of Lupus Erythematosus: A Case Series and Literature Review

Lupus erythematosus (LE) is an autoimmune disease that presents either as a systemic (SLE) or an isolated skin disease (CLE). Currently, there is no FDA-approved medication specifically for CLE, and is treated with the same approach as SLE. We present two refractory cases of SLE with severe cutaneou...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad Atif, Khan, Faiza Humayun, Khan, Hina Benish, Saadeh, Constantine, Davey, Nichole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292022/
https://www.ncbi.nlm.nih.gov/pubmed/37378095
http://dx.doi.org/10.7759/cureus.39553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292022/
https://www.ncbi.nlm.nih.gov/pubmed/37378095
http://dx.doi.org/10.7759/cureus.39553

Ejemplares similares